GREM1 is a novel serum diagnostic marker and potential therapeutic target for pancreatic ductal adenocarcinoma

OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant neoplasm with rising incidence worldwide. Gremlin 1 (GREM1), a regulator of bone morphogenetic protein (BMP) signaling, fine-tunes extensive biological processes, including organ morphology, cellular metabolism, and multiple pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sen, Zhang, Yalu, Hua, Yuze, Cui, Ming, Wang, Mengyi, Gao, Junyi, Liu, Qiaofei, Liao, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458890/
https://www.ncbi.nlm.nih.gov/pubmed/36091126
http://dx.doi.org/10.3389/fonc.2022.968610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458890/
https://www.ncbi.nlm.nih.gov/pubmed/36091126
http://dx.doi.org/10.3389/fonc.2022.968610

Ejemplares similares